BruesA. M.StroudA. N.RietzL.: Toxicity of tritium oxide to mice. Proc. Soc. Exper. Biol. Med.79 (1952), 174.
3.
CaterD. B.PhillipsA. F.: Measurement of electrode potentials in living and dead tissues. Nature, Lond.174 (1954), 121.
4.
CaterD. B.PhillipsA. F.SilverI. A.: The measurement of oxidation-reduction potentials and oxygen tension as a tool for the investigation of chemotherapeutic drugs in vivo. G. Ital. Chemoterapia, 3 (1956), 269.
5.
CaterD. B.PhillipsA. F.SilverI. A.: Apparatus and techniques for the measurement of oxidation-reduction potentials, pH and oxygen tension in vivo. Proc. Roy. Soc. B.146 (1957a), 289.
6.
CaterD. B.PhillipsA. F.SilverI. A.: The measurement of oxidation-reduction potentials, pH and oxygen tension in tumours. Proc. Roy. Soc. B146 (1957b), 382.
7.
CaterD. B.PhillipsA. F.SilverI. A.: Induced changes in oxidation-reduction potentials, pH and oxygen tension in the intact lactating mammary gland. Proc. Roy. Soc. B146 (1957c), 400.
8.
CaterD. B.SilverI. A.WilsonG. M.: Apparatus and technique for the quantitative measurement of oxygen tension in living tissues. Proc. Roy. Soc. B. (1959) in the press.
9.
CurranS. C.AngusJ.CockcroftA. L.: Beta spectrum of tritium. Nature162 (1948), 302.
10.
FallotP.AeberhardtA.: Use of tritium-containing water as an indicator of water metabolism in normal and post-operative subjects. Proc. Internat. Conf. on Peaceful Uses of Atomic Energy, Geneva, 1955. Vol. 10 (1956), 453.
11.
FriedmannE.MarrianD. H.Simon-ReussI.: Halogen derivatives of the 1:4-naphthoquinone group and the maleic acid series in their action on the mitosis of chick fibroblasts. Biochim. Biophys. Acta8 (1952), 680.
12.
GlascockR. F.: Isotopic gas analysis for biochemists. 1954. Academic Press Inc., New York.
13.
FurchnerJ. E.: Relative biological effectiveness of tritium beta-particles and Co60 gamma-rays measured by lethality in CFl Mice. Radiation Research7 (1957), 483.
14.
FurchnerJ. E.LotzV.StorerJ.: The relative biological effectiveness of tritium in depressing iron uptake in rats. Los Alamos Scientific Laboratory. Report LA-1544 (1953).
15.
GreggD. McC.: Renal aortography and selective renal arteriography. Postgraduate Medical Journal34 (1958), 149.
16.
GreggD.McC., J. M. Allcock, and F. R. Berridge: Percutaneous transfemoral renal arteriography (including cineradiology) Brit. J. Radiol.30 (1957), 423.
17.
HallB. V.StroudA. N.: ANL-4451 (1950) 66, quoted by Sacher (1954).
18.
HevesyG.HoferE.: Elimination of water from the human body. Nature134 (1934), 879.
19.
I. C. R. P.: Recommendations of the International Commission on Radiological Protection (1954). Brit. J. Radiol.Suppl. 6 (1955).
20.
JenksG. H.GhormleyJ. A.SweetonF. H.: Measurement of the half-life and average energy of tritium decay. Physical Rev.75 (1949), 701.
21.
MarrianD. H.: Tritium-labelled 2-methyl-1:4-naphthoquinone and confirmation of the structure of its adduct with sodium hydrogen sulphite. J. Chem. Soc. (1957), 499.
22.
MarrianD. H.: Studies of potential radiosensitizing agents. Part III. An effect of tetra-sodium 2-methyl-1:4-naphthohydroquinone diphosphate (Synkavit) on the Ehrlich mouse ascites tumour. Brit. J. Cancer, in the press.
23.
MarrianD. H.MaxwellD. R.: Tracer studies of potential radiosensitizing agents. Tetra-sodium 2-methyl-3-82Br-bromo-1:4-naphthohydroquinone diphosphate and tetra-sodium 2:3-dimethyl-5:6-di-131I-iodo-1:4-benzohydroquinone diphosphate. Brit. J. Cancer 10 (1956a), 739.
24.
MarrianD. H.MaxwellD. R.: Tracer studies of potential radiosensitizing agents. Tetra-sodium 2-14C-methyl-1:4-naphthohydroquinone diphosphate. Brit. J. Cancer10 (1956b), 575.
25.
MaxwellD. R.: Some experiments with labelled compounds related to 2-methyl-1:4-naphthohydroquinone diphosphate (Synkavit). Second Radio-isotope Conference, Oxford. 1954. Butterworths, London p. 200.
26.
MaxwellD. R.: Studies of chemotherapeutic agents which incorporate radio-active atoms and may concentrate in malignant tumour cells. Ph. D. Thesis, University of Cambridge.
27.
MitchellJ. S.: Laboratory studies and clinical investigations of chemical agents as radiosensitizers in conjunction with X-Ray therapy. Ann. Rep. Brit. Emp. Cancer Camp.30 (1952), 238.
28.
MitchellJ. S.: Laboratory studies and clinical therapeutic trials of some chemical radiosensitizers. Acta Radiol. Stockh.Suppl. 116 (1953), 431.
29.
MitchellJ. S.: Laboratory studies and clinical trials of some chemical radiosensitizers. Radiobiology Symposium, Liège 1954, Butterworths, London.
30.
MitchellJ. S.: Studies in Radiotherapeutics. 1959. Blackwells, Oxford. In the press.
31.
MitchellJ. S.Simon-ReussI.: Combination of some effects of X-radiation and a synthetic Vitamin K substitute. Nature160 (1947), 98.
32.
MitchellJ. S.Simon-ReussI.: Experiments on the mechanism of action of tetra-sodium 2-methyl-1:4-naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitizer, using the technique of tissue culture. Experimental methods and quantitative resultsBrit. J. Cancer6 (1952), 305.
33.
MitchellJ. S.Simon-ReussI.KingE. A.: Some recent laboratory studies of chemical radiosensitizers. Paper read at Seventh Intern. Cancer Congr., London, 1958 and Acta Un. int. Cancer. In the press.
34.
SacherG. A.: The lethality function for exponentially decaying exposure: Application to the toxicity of tritium. Argonne National Laboratory Report ANL-5288 (1954), 16.
35.
SeldingerS. I.: Catheter replacement of the needle in percutaneous arteriography. Acta Radiol.39 (1953), 368.
36.
SchloerbP. R.Friis-HansenB. J.EdelmanJ. S.SolomonA. K.MooreF. D.: The measurement of total body water in the human subject by deuterium oxide dilution. J. Clin. Invest.29 (1950), 1296.
37.
ThompsonR. C.: Biological applications of tritium. Nucleonics12 (1954), 31.
38.
WilzbachK. E.: Tritium-labelling by exposure of organic compounds to tritium gas. J. Amer. Chem Soc.79 (1957), 1013.
39.
WormanF. C. V.TurneyD. F.LotzV.: The relative biological effectiveness of tritium beta rays in producing splenic and thymic atrophy. Los Alamos Scientific Laboratory Report LA-1641 (1954).